Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bone matrix is the non-cellular component of bone tissue, providing structural support and serving as a reservoir for minerals. It is primarily composed of collagen fibers (mainly type I collagen), non-collagenous proteins, and mineral deposits such as hydroxyapatite. Areas of altered osteogenesis refer to regions within the bone matrix where normal bone formation or remodeling processes are disrupted or modified, often due to disease, injury, or genetic conditions.
Various mechanisms depending on the drug; PTH analogs stimulate bone formation and resorption; Bisphosphonates inhibit osteoclast activity; Denosumab inhibits RANKL
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone Matrix (areas of altered osteogenesis).